RHIZEN PHARMA
Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater ChinaAs per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commerc...13 Oct, 2020, 10.46 AM IST
Alembic Pharma raises Rs. 750 crore via QIPThe issue was subscribed at a price of Rs. 932 a share, lower than Thursday’s close at Rs. 1081.55 a share on Bombay Stock Exchange.06 Aug, 2020, 07.38 PM IST
Alembic Pharma arm ties up with Novartis for drug developmentAlembic Pharmaceuticals group firm Rhizen Pharmaceuticals SA has entered into an exclusive worldwide license agreement with Novartis.10 Dec, 2015, 03.17 PM IST
Load More